Alphamab Oncology (HKG:9966)

Alphamab Oncology Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 20, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	9,134	3,368	6,407	10,149	12,743	15,221
Market Cap Growth	162.18%	-47.42%	-36.88%	-20.36%	-16.28%	21.20%
Enterprise Value	7,631	2,154	5,004	8,763	10,814	12,776
Last Close Price	9.43	3.50	6.64	10.80	13.60	16.28
PE Ratio	36.42	19.03	-	-	-	-
PS Ratio	10.61	4.95	26.58	53.81	71.10	-
PB Ratio	4.49	1.73	3.48	5.76	5.55	5.64
P/TBV Ratio	4.49	1.73	3.48	5.76	5.55	5.64
P/FCF Ratio	38.30	16.61	-	-	-	-
P/OCF Ratio	32.50	14.91	-	-	-	-
EV/Sales Ratio	8.86	3.16	20.76	46.46	60.34	-
EV/EBITDA Ratio	26.84	12.24	-	-	-	-
EV/EBIT Ratio	37.03	20.04	-	-	-	-
EV/FCF Ratio	32.00	10.62	-	-	-	-
Debt / Equity Ratio	0.15	0.10	0.15	0.22	0.34	0.10
Debt / EBITDA Ratio	1.05	1.04	-	-	-	-
Debt / FCF Ratio	1.26	0.98	-	-	-	-
Asset Turnover	0.35	0.29	0.10	0.07	0.06	-
Inventory Turnover	0.83	0.75	0.77	0.72	0.06	-
Quick Ratio	4.76	6.41	5.55	3.72	3.22	6.52
Current Ratio	4.98	6.74	5.84	3.88	3.32	6.67
Return on Equity (ROE)	13.37%	9.49%	-13.04%	-19.00%	-19.91%	-18.21%
Return on Assets (ROA)	5.22%	2.88%	-9.50%	-11.21%	-9.72%	-9.32%
Return on Capital Employed (ROCE)	9.40%	5.10%	-17.30%	-25.00%	-20.10%	-17.70%
Earnings Yield	2.79%	5.25%	-3.62%	-3.63%	-3.97%	-3.34%
FCF Yield	2.61%	6.02%	-4.11%	-4.79%	-4.61%	-3.42%
Buyback Yield / Dilution	-3.37%	-2.53%	-2.50%	-0.11%	-0.62%	-73.29%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.